Bialasiewicz A A, Ma J X, Richard G
Augenklinik mit Poliklinik, Universitäts-Krankenhauses Eppendorf, Hamburg.
Klin Monbl Augenheilkd. 1998 Nov;213(5):271-7. doi: 10.1055/s-2008-1034987.
T-cell receptor (TCR) gene analysis of tumor infiltrating lymphocytes (TIL) has been recognized to play a pivotal role in the immunosurveillance of solid neoplasms.
Therefore, 113 necrotizing choroidal melanomas (NMM) were compared to 100 non-necrotizing melanomas (MM) histologically and immunohistochemically.
NMM showed TIL more frequently (76.11% vs. 21%, p < 0.001). V alpha/V beta- (70.3% of NMM) and V gamma 1- (39.2% of NMM) and V delta 1- (52.7% of NMM) TCR+ cells were distributed focal or diffuse, and correlated with tumor volume, diameter, and scleral invasion. 74.33% of NMM patients had died after 240 months (5 year survival: 58.1%). Mortality was not significantly associated with TIL (p < 0.33) or V alpha/V beta-TCR+ cells (p < 0.2), however, survival was significantly increased with evidence of V gamma 1- and V delta 1-TCR+ cells (p < 0.026).
V alpha/V beta-, V gamma 1- and V delta 1-TCR+ tumor infiltrating lymphocytes can be demonstrated in choroidal melanomas. This is a basis for functional studies providing a rationale for the evaluation of immunotherapeutic modalities.
肿瘤浸润淋巴细胞(TIL)的T细胞受体(TCR)基因分析已被认为在实体瘤的免疫监视中起关键作用。
因此,对113例坏死性脉络膜黑色素瘤(NMM)与100例非坏死性黑色素瘤(MM)进行了组织学和免疫组织化学比较。
NMM更频繁地出现TIL(76.11%对21%,p<0.001)。Vα/Vβ-(70.3%的NMM)、Vγ1-(39.2%的NMM)和Vδ1-(52.7%的NMM)TCR+细胞呈局灶性或弥漫性分布,并与肿瘤体积、直径和巩膜侵犯相关。74.33%的NMM患者在240个月后死亡(5年生存率:58.1%)。死亡率与TIL(p<0.33)或Vα/Vβ-TCR+细胞(p<0.2)无显著相关性,然而,Vγ1-和Vδ1-TCR+细胞的存在使生存率显著提高(p<0.026)。
在脉络膜黑色素瘤中可检测到Vα/Vβ-、Vγ1-和Vδ1-TCR+肿瘤浸润淋巴细胞。这为功能研究提供了基础,为评估免疫治疗方式提供了理论依据。